Fielmann Aktiengesellschaft (FIE.DE)
EUR 52.5
(5.0%)
EUR 52.5
(5.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.95 Million EUR | -98.19% |
| 2022 | 384.55 Million EUR | 4.43% |
| 2021 | 368.25 Million EUR | 7.44% |
| 2020 | 342.74 Million EUR | 15.54% |
| 2019 | 296.63 Million EUR | 23918.87% |
| 2018 | 1.23 Million EUR | -20.58% |
| 2017 | 1.55 Million EUR | 18.7% |
| 2016 | 1.31 Million EUR | 37.89% |
| 2015 | 950 Thousand EUR | -19.22% |
| 2014 | 1.17 Million EUR | 19.76% |
| 2013 | 982 Thousand EUR | -20.1% |
| 2012 | 1.22 Million EUR | -71.35% |
| 2011 | 4.29 Million EUR | 0.0% |
| 2010 | - EUR | -100.0% |
| 2009 | 8.21 Million EUR | 12.31% |
| 2008 | 7.31 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 413.06 Million EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2023 Q1 | 371.56 Million EUR | -3.38% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q2 | 354.67 Million EUR | -4.54% |
| 2023 Q4 | 421.1 Million EUR | 0.0% |
| 2023 FY | 6.95 Million EUR | -98.19% |
| 2022 Q2 | 368.27 Million EUR | 0.61% |
| 2022 Q1 | 366.04 Million EUR | -0.6% |
| 2022 Q3 | 366 Million EUR | -0.62% |
| 2022 FY | 384.55 Million EUR | 4.43% |
| 2022 Q4 | 384.55 Million EUR | 5.07% |
| 2021 Q1 | 339.78 Million EUR | -0.86% |
| 2021 Q3 | 362.05 Million EUR | 5.49% |
| 2021 Q4 | 368.25 Million EUR | 1.71% |
| 2021 FY | 368.25 Million EUR | 7.44% |
| 2021 Q2 | 343.21 Million EUR | 1.01% |
| 2020 Q3 | 269.67 Million EUR | -2.12% |
| 2020 FY | 342.74 Million EUR | 15.54% |
| 2020 Q4 | 342.74 Million EUR | 27.1% |
| 2020 Q2 | 275.51 Million EUR | -4.51% |
| 2020 Q1 | 288.52 Million EUR | -2.73% |
| 2019 Q4 | 296.63 Million EUR | -2.39% |
| 2019 Q3 | 303.91 Million EUR | 0.44% |
| 2019 Q2 | 302.57 Million EUR | -0.58% |
| 2019 FY | 296.63 Million EUR | 23918.87% |
| 2019 Q1 | 304.34 Million EUR | 24543.32% |
| 2018 Q3 | 594 Thousand EUR | -53.56% |
| 2018 Q1 | 1.5 Million EUR | -2.96% |
| 2018 FY | 1.23 Million EUR | -20.58% |
| 2018 Q2 | 1.27 Million EUR | -15.24% |
| 2018 Q4 | 1.23 Million EUR | 107.91% |
| 2017 FY | 1.55 Million EUR | 18.7% |
| 2017 Q4 | 1.55 Million EUR | -29.48% |
| 2017 Q3 | 2.2 Million EUR | 12.44% |
| 2017 Q2 | 1.96 Million EUR | 14.41% |
| 2017 Q1 | 1.71 Million EUR | 30.84% |
| 2016 Q2 | 1.34 Million EUR | -4.26% |
| 2016 FY | 1.31 Million EUR | 37.89% |
| 2016 Q4 | 1.31 Million EUR | 1.55% |
| 2016 Q3 | 1.29 Million EUR | -4.23% |
| 2016 Q1 | 1.4 Million EUR | 48.11% |
| 2015 FY | 950 Thousand EUR | -19.22% |
| 2015 Q1 | 1.96 Million EUR | 67.01% |
| 2015 Q4 | 950 Thousand EUR | -48.31% |
| 2015 Q3 | 1.83 Million EUR | -3.31% |
| 2015 Q2 | 1.9 Million EUR | -3.21% |
| 2014 Q2 | 2 Million EUR | -1.18% |
| 2014 Q1 | 2.02 Million EUR | 106.31% |
| 2014 FY | 1.17 Million EUR | 19.76% |
| 2014 Q4 | 1.17 Million EUR | -40.06% |
| 2014 Q3 | 1.96 Million EUR | -2.0% |
| 2013 Q1 | 2.39 Million EUR | 94.96% |
| 2013 FY | 982 Thousand EUR | -20.1% |
| 2013 Q4 | 982 Thousand EUR | -56.78% |
| 2013 Q3 | 2.27 Million EUR | -2.78% |
| 2013 Q2 | 2.33 Million EUR | -2.46% |
| 2012 Q4 | 1.22 Million EUR | -54.35% |
| 2012 Q3 | 2.69 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2012 FY | 1.22 Million EUR | -71.35% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | 4.29 Million EUR | 0.0% |
| 2011 FY | 4.29 Million EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 FY | - EUR | -100.0% |
| 2010 Q4 | 4.98 Million EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 FY | 8.21 Million EUR | 12.31% |
| 2009 Q4 | 8.21 Million EUR | 0.0% |
| 2008 FY | 7.31 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 69.19 Million EUR | 89.948% |
| Carl Zeiss Meditec AG | 133.88 Million EUR | 94.805% |
| Gerresheimer AG | 658.49 Million EUR | 98.944% |
| Sartorius Aktiengesellschaft | 5.02 Billion EUR | 99.862% |
| Sartorius Aktiengesellschaft | 5.02 Billion EUR | 99.862% |